" class="no-js "lang="en-US"> Dominic Borie - Medtech Alert
Tuesday, August 05, 2025
Dominic Borie

Dominic Borie

About Dominic Borie

Pharmaceutical executive with 18+ years experience in drug development spanning target discovery and validation, first-in-human studies, dose-ranging and pivotal trials, and medical affairs activities. Experienced drug-developer, designing/overseeing clinical trials in various fields of inflammation such as but not limited to inflammatory bowel diseases, rheumatoid arthritis, psoriasis, and organ transplantation. Experienced in interacting with global (US &EU) health authorities, including filing of INDs, CTAs, and sBLAs. Experienced leader of cross-functional teams (e.g. Development, Commercialization, Regulatory, Safety, Manufacturing, Payer). Experienced in interacting with key opinion leaders (both US and EU) and in setting up and running advisory boards and investigator meetings. Physician-scientist (Immunologist) with extensive experience in life-science research; both in academic and industry environments. Experienced digestive tract and liver transplant surgeon with 15+ years experience in the French healthcare system and in the treatment and monitoring of liver transplant recipients and patients with gastro-intestinal diseases (IBD, cancer).

Related Story

Kyverna Therapeutics Announces Exclusive Worldwide Licenses With National Institutes of Health for Autologous and Allogeneic Anti-CD19 CAR T Cellular Therapies to Treat Autoimmune Diseases

January 4 2022

Kyverna Therapeutics (“Kyverna”), a cell therapy company engineering a new class of therapies for autoimmune […]